Prognostic value of Bak expression in oral tongue squamous cell carcinomas

Oncology Reports

Volumn 10, Issue 2, 2003, Pages 369-374

  Xie, Xin ^a   Clausen, Ole Petter F ^a   Boysen, Morten ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Apoptosis; Bak; Prognosis; Tongue squamous cell carcinoma

Indexed keywords

BAK1 PROTEIN, HUMAN; BAX PROTEIN, HUMAN; MEMBRANE PROTEIN; ONCOPROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; DISEASE FREE SURVIVAL; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NICK END LABELING; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TONGUE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037810726     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.2.369     Document Type: Article

References (38)

1. Searle J, Collins DJ, Harmon B and Kerr JF: The spontaneous occurrence of apoptosis in squamous carcinomas of the uterine cervix. Pathology 5; 163-169, 1973.
2. Wyllie AH: The biology of cell death in tumours. Anticancer Res 5: 131-136, 1985.
3. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
4. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3: 614-620, 1997.
5. Farrow SN and Brown R: New members of the Bcl-2 family and their protein partners. Curr Opin Genet Dev 6: 45-49, 1996.
6. Yin XM, Oltvai ZN and Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321-323, 1994. (Pubitemid 24159542)
7. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993. (Pubitemid 23259742)
8. Reed JC: Bcl-2; prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 9: 451-473, 1995.
9. Green D and Kroemer G; The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol 8: 267-271, 1998. (Pubitemid 28310224)
10. Gross A, Jockel J, Wei MC and Korsmeyer SJ: Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 17: 3878-3885, 1998. (Pubitemid 28333974)
11. Shimizu S, Narita M and Tsujimoto Y: Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483-487, 1999. (Pubitemid 29258855)
12. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI and Guild BC: Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374: 733-736, 1995.
13. Farrow SN, White JH, Martinou I, Raven T, Pun KT, Grinham CJ, Martinou JC and Brown R: Cloning of a bcl-2 homologue by interaction with adenovirus EIB 19K. Nature 374: 731-733, 1995.
14. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD and Barr PJ: Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374: 736-739, 1995.
15. Jones NA, Turner J, McIlwrath AJ, Brown R and Dive C: Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. Mol Pharmacol 53: 819-826, 1998. (Pubitemid 28244068)
16. Luo D, Cheng SC and Xie Y; Expression of Bcl-2 family proteins during chemotherapeutic agents-induced apoptosis in the hepatoblastoma HepG2 cell line. Br J Biomed Sci 56: 114-122, 1999. (Pubitemid 29335605)
17. Ruemmele FM, Dionne S, Qureshi I, Sarma DS, Levy E and Seidman EG: Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Differ 6: 729-735, 1999. (Pubitemid 29425383)
18. Chittenden T, Flemington C, Houghton AB, Ebb RG, Gallo GJ, Elangovan B, Chinnadurai G and Lutz RJ: A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J 14: 5589-5596, 1995.
19. Ink B, Zornig M, Baum B, Hajibagheri N, James C, Chittenden T and Evan G: Human Bak induces cell death in Schizosaccharomyces pombe with morphological changes similar to those with apoptosis in mammalian cells. Mol Cell Biol 17: 2468-2474, 1997. (Pubitemid 27175127)
20. Holinger EP, Chittenden T and Lutz RJ: Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases. J Biol Chem 274: 13298-13304, 1999.
21. Bairey O, Zimra Y, Shaklai M, Okon E and Rabizadeh E: Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas. Clin Cancer Res 5: 2860-2866, 1999. (Pubitemid 29493964)
22. Borner MM, Brousset P, Pfanner-Meyer B, Bacchi M, Vonlanthen S, Hotz MA, Altermatt HJ, Schlaifer D, Reed JC and Betticher DC: Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small cell lung cancer. Br J Cancer 79: 952-958, 1999. (Pubitemid 29082132)
23. Hotz MA, Bosq J, Zbaeren P, Reed J, Schwab G, Krajewski S, Brousset P and Borner MM: Spontaneous apoptosis and the expression of p53 and Bcl-2 family proteins in locally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 125: 417-422, 1999. (Pubitemid 29169768)
24. Ogura E, Senzaki H, Yamamoto D, Yoshida R, Takada H, Hioki K and Tsubura A: Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas. Oncol Rep 6: 365-369, 1999.
25. Xie X, Clausen OPF, De Angelis P and Boysen M: Prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in tongue squamous cell carcinoma. Cancer 86: 913-920, 1999. (Pubitemid 29439843)
26. Xie X, De Angelis P, Clausen OPF and Boysen M: Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas. Br J Cancer 78: 100-105, 1998. (Pubitemid 28276777)
27. Pammer J, Exner M, Regele H, Haitel A, Weninger W, Horvat R and Susani M: Expression of bcl-2, bcl-x, bax and bak in renal parenchyma, oncocytomas and renal cell carcinomas. Pathol Res Pract 194: 837-845, 1998. (Pubitemid 29012245)
28. Friedman M, Grey P, Venkatesan TK, Bloch I, Chawla P, Caldarelli DD and Coon JS: Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol 106: 445-450, 1997. (Pubitemid 27259863)
29. Marx D, Binder C, Meden H, Lenthe T, Ziemek T, Hiddemann T, Kuhn W and Schauer A: Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer. Anticancer Res 17: 2233-2240, 1997. (Pubitemid 27320975)
30. Lipponen P, Pietilainen T, Kosma VM, Aaltomaa S, Eskelinen M and Syrjanen K: Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J Pathol 177: 49-55, 1995.
31. Wilson GD, Grover R, Richman PI, Daley FM, Saunders MI and Dische S: Bcl-2 expression correlates with favourable outcome in head and neck cancer treated by accelerated radiotherapy. Anticancer Res 16: 2403-2408, 1996. (Pubitemid 26326270)
32. Uehara T, Kuwashima Y, Izumo T, Kishi K, Shiromizu K and Matsuzawa M: Expression of the proto-oncogene bcl-2 in uterine cervical squamous cell carcinoma: its relationship to clinical outcome. Eur J Gynaecol Oncol 16: 453-460, 1995.
33. Spafford MF, Koeppe J, Pan Z, Archer PG, Meyers AD and Franklin WA: Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 122: 627-632, 1996. (Pubitemid 26178794)
34. Koshida Y, Saegusa M and Okayasu I: Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: immunohistochemical and clinicopathological study. Br J Cancer 75: 367-373, 1997. (Pubitemid 27051051)
35. Pearson AS, Spitz FR, Swisher SG, Kataoka M, Sarkiss MG, Meyn RE, McDonnell TJ, Cristiano RJ and Roth JA: Upregulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells. Clin Cancer Res 6: 887-890, 2000. (Pubitemid 30159345)
36. Frederick MJ, Holton PR, Hudson M, Wang M and dayman GL: Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death. Clin Cancer Res 5: 361-369, 1999. (Pubitemid 29085190)
37. Xie X, De Angelis P, Clausen OPF and Boysen M: Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas. Oral Oncol 35: 502-509, 1999. (Pubitemid 29386787)
38. y and H antigens in oral tongue carcinomas. Laryngoscope 109: 1474-1480, 1999.